Adenovirus‐mediated overexpression of tissue inhibitor of metalloproteinases‐1 in the liver: efficient protection against T‐cell lymphoma and colon carcinoma metastasis
- 23 September 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (11) , 1228-1237
- https://doi.org/10.1002/jgm.637
Abstract
Background Matrix metalloproteinases (MMPs) are critical for metastasis of tumor cells. Tissue inhibitor of metalloproteinases‐1 (TIMP‐1), a natural MMP inhibitor, was shown to reduce metastasis in different models. Here, we investigated whether increased TIMP‐1 levels in the liver achieved by adenoviral gene transfer will effectively inhibit liver metastasis of two independent tumor cell lines. Method TIMP‐1 was transferred with adenoviral vectors into the livers of DBA/2 and Balb/c mice, which were subsequently challenged by hematogenous experimental metastases of the T‐cell lymphoma cell line L‐CI.5s or the colorectal carcinoma cell line CT‐26, respectively. Results MMP‐9 expression in the liver was induced upon metastasis in both tumor types. Adenoviral gene transfer led to high transduction efficacy as indicated by lacZ expression in 60% of hepatocytes. TIMP‐1, a key inhibitor of MMP‐9, was expressed at 105‐fold higher levels by adenoviral gene transfer as compared with levels achieved in TIMP‐1 transgenic mice, previously shown to be inefficient to reduce T‐cell lymphoma metastasis. High local and systemic (serum) levels of TIMP‐1 led to substantial (94%) reduction of T‐cell lymphoma and colorectal carcinoma (73%) experimental liver metastasis. Conclusions Adenoviral gene transfer led to systemic and local TIMP‐1 levels sufficient to inhibit metastasis of a highly aggressive T‐cell lymphoma, pointing at the requirement of threshold levels for effective anti‐metastatic efficacy. This approach was also efficient in a colon carcinoma solid tumor model. We propose that viral gene transfer of TIMP‐1 can provide a suitable defense strategy to prevent metastatic spread to the liver. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft Sonderforschungsbereich SFB-469
- Project B13
- European Union Framework Programme 6 (LSHC-CT-2003-503297)
This publication has 41 references indexed in Scilit:
- Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3Molecular Therapy, 2002
- Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infectionGene Therapy, 1999
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell lineOncogene, 1998
- Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cellsMatrix Biology, 1996
- TIMP-2 Growth-Stimulatory Activity: A Concentration- and Cell Type-Specific Response in the Presence of InsulinExperimental Cell Research, 1996
- Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric AcetateJournal of Biological Chemistry, 1995
- Scattered micrometastases visualized at the single‐cell level: Detection and re‐isolation of lacZ‐labeled metastasized lymphoma cellsInternational Journal of Cancer, 1994
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Isolation of deletion and substitution mutants of adenovirus type 5Cell, 1978